XVIVO Perfusion System (XPS) with STEEN Solution Perfusate
FDA premarket approval P180014/S008 · decided 2022-05-09
Approval details
- PMA number
- P180014
- Supplement
- S008
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- XVIVO Perfusion System (XPS) with STEEN Solution Perfusate
- Generic name
- Normothermic preservation system for transplantation of initially unacceptable donor lungs
- Applicant
- Xvivo Perfusion, Inc.
- Date received
- 2022-02-08
- Decision date
- 2022-05-09
- Days to decision
- 90 days
- Decision code
- APPR
- Product code
- PHO
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Englewood, CO
- Statement
- Approval for a software upgrade in the XPS (software v5.3.0) to address minor bug fixes and to remove the software control of XPS auxiliary pumps.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.